Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02238 (Long intergenic non-protein coding RNA 2238, also known as RP4-788P17.1) is a non-protein coding gene classified as a long intergenic non-coding RNA (lincRNA)[1][3]. LincRNAs are a subclass of long non-coding RNAs (lncRNAs) that are transcribed from intergenic regions and do not overlap coding genes. They typically function in gene regulation, including chromatin remodeling, RNA stabilization, and modulation of gene transcription, often through interactions with chromatin-modifying complexes or by scaffolding proteins[3][5]. The specific function of LINC02238 has not been determined, and there is no evidence to support its role as a therapeutic target or disease biomarker in current databases or experimental literature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2238 (LINC02238).